CO-PRESENTING PARTNER
LIVE COVERAGE AND VIDEO PARTNERS
CO-PRESENTING PARTNER
LIVE COVERAGE AND VIDEO PARTNERS
Glenmark Pharma share price gains intraday on January 28 after the company received final approval from the United States Food & Drug Administration (US FDA).
Glenmark Pharmaceuticals has received final approval by the United States Food & Drug Administration (USFDA) for Amphetamine Sulfate Tablets USP, 5 mg and 10 mg, the generic version of Evekeo Tablets, 5 mg and 10 mg, of Arbor Pharmaceuticals, LLC, company said in a release.
According to IQVIATM sales data for the 12 month period ending November 2020, the Evekeo Tablets, 5 mg and 10 mg market2 achieved annual sales of approximately USD 21.5 million.
Glenmark’s current portfolio consists of 168 products authorized for distribution in the US marketplace and 43 ANDA’s pending approval with the USFDA.
